The Medicines and Health products Regulatory Agency (MHRA) has issued a class two medicines recall for Epilim 500mg gastro-resistant tablets (PL 04425/0303) of Sanofi.
Sanofi has informed the MHRA that it is recalling the product batches as a precautionary measure due to out of specification results for disintegration test during routine stability testing.
Product details
| Batch Number | Expiry Date | Pack Size | First Distributed |
| R0601 | 08/2022 | 30 | November 6, 2019 |
| R0602 | 08/2022 | 30 | November 5, 2019 |
| R0603 | 08/2022 | 30 | November 6, 2019 |
The healthcare professionals have been advised to stop supplying the product batches immediately and quarantine all stock and return it to their supplier using their supplier’s approved process.
